What is the fair value of Positron Corp (OTC-POSC) stock?

The current fair value estimate for Positron Corp (OTC-POSC) is $1.11. This implies an estimated downside of 40.5% versus the current market price.

Is Positron Corp (OTC-POSC) undervalued or overvalued?

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 40.5% versus the current market price.

How is the financial health of Positron Corp?

The current financial health read for Positron Corp (OTC-POSC) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Does Positron Corp (OTC-POSC) pay dividends?

The latest available data indicates no current dividend yield for Positron Corp (OTC-POSC).

What is the market capitalization of Positron Corp?

The current market capitalization listed for Positron Corp is 61.257 M.

What is the enterprise value of Positron Corp?

The current enterprise value listed for Positron Corp is 58.167 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Positron Corp?

The ticker symbol for Positron Corp is OTC-POSC, and the stock is listed on OTC Markets.

Where is Positron Corp (OTC-POSC) listed?

Positron Corp (OTC-POSC) is listed on OTC Markets.

What is the debt-to-total-capital ratio for Positron Corp?

The current debt-to-total-capital ratio listed for Positron Corp is 1.8%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Positron Corp?

The free float listed for Positron Corp is 45.4%. Free float helps investors understand how much of the share base is available for public trading.

Positron Corp (POSC) Fair Value & Stock Analysis

Positron Corp (POSC)

Positron Corp is a healthcare equipment company focused on cardiac positron emission tomography (PET) imaging systems in the United States. The company develops, manufactures, and sells products including Attrius PET and NeuSight PET-CT 64-slice, which are used in the non-invasive diagnosis and evaluation of coronary artery disease and in molecular imaging applications across cardiology, oncology, and neurology. Positron also provides clinical and technical support services, such as training for physicians, nurses, and technologists, billing and prior-authorization assistance, physician over-read services, 24/7 support, priority response, software updates, and remote diagnostics and maintenance. Its products are marketed through an internal sales and marketing team to healthcare providers, imaging centers, hospitals, and cardiovascular disease specialists. Incorporated in 1983, Positron is headquartered in North Tonawanda, New York, and its common stock trades on OTC Markets under the symbol POSC.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Overall Financial Health	Dividend Yield	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Free Cash Flow / Net Income
OTC-POSC	$1.11	-40.5% Downside	Overvalued	Not available	Not available	Fair	0.0%	129.2x	61.257 M	58.167 M	1.8%	45.4%	-124.4	42.7%